Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
H9F3L4
|
Breast cancer type 1 susceptibility protein isoform 3; Fragment;
|
BRCA1;
|
NULL
|
559
|
Rhesus-monkey
|
H9F392
|
Cytochrome P450 2A13; Fragment;
|
CYP2A13;
|
NULL
|
176
|
Rhesus-monkey
|
H9F5G6
|
Transmembrane protein 222; Fragment;
|
TMEM222;
|
NULL
|
204
|
Rhesus-monkey
|
H9F8I0
|
Transcription initiation factor TFIID subunit 5; Fragment;
|
TAF5;
|
NULL
|
219
|
Rhesus-monkey
|
H9F928
|
Filamin-B isoform 4; Fragment;
|
FLNB;
|
NULL
|
2530
|
Rhesus-monkey
|
H9F8W3
|
Potassium channel subfamily T member 2; Fragment;
|
KCNT2;
|
NULL
|
269
|
Rhesus-monkey
|
H9F050
|
Protein CIP2A; Fragment;
|
KIAA1524;
|
NULL
|
128
|
Rhesus-monkey
|
H9ES84
|
Putative G-protein coupled receptor 75;
|
GPR75;
|
NULL
|
540
|
Rhesus-monkey
|
H9EPP9
|
Clathrin light chain A isoform e;
|
CLTA;
|
NULL
|
168
|
Rhesus-monkey
|
H9FDH9
|
Retinoic acid-induced protein 2 isoform 1; Fragment;
|
RAI2;
|
NULL
|
68
|
Rhesus-monkey
|
G7N5I5
|
Voltage-gated calcium channel subunit alpha-2/delta-4;
|
NULL
|
NULL
|
1137
|
Rhesus-monkey
|
H9FDU0
|
NACHT and WD repeat domain-containing protein 1; Fragment;
|
NWD1;
|
NULL
|
210
|
Rhesus-monkey
|
H9FCQ2
|
Uncharacterized protein C2orf55; Fragment;
|
C2orf55;
|
NULL
|
117
|
Rhesus-monkey
|
H9FEQ5
|
Myeloid zinc finger 1 isoform 1; Fragment;
|
MZF1;
|
NULL
|
336
|
Rhesus-monkey
|
H9FF47
|
Calcyphosin-2; Fragment;
|
CAPS2;
|
NULL
|
171
|
Rhesus-monkey
|
H9FIB7
|
Prokineticin receptor 2; Fragment;
|
PROKR2;
|
NULL
|
127
|
Rhesus-monkey
|
H9FJC7
|
Uncharacterized protein KIAA2022; Fragment;
|
KIAA2022;
|
NULL
|
275
|
Rhesus-monkey
|
H9FF46
|
Laminin subunit alpha-3 isoform 4; Fragment;
|
LAMA3;
|
NULL
|
214
|
Rhesus-monkey
|
H9FIU2
|
Chondroitin sulfate glucuronyltransferase; Fragment;
|
CHPF2;
|
NULL
|
327
|
Rhesus-monkey
|
H9FE10
|
Coiled-coil domain-containing protein 164; Fragment;
|
C2orf39;
|
NULL
|
114
|
Rhesus-monkey
|